vs
Cibus, Inc.（CBUS）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Cibus, Inc.的季度营收约是Arcadia Biosciences, Inc.的1.2倍（$1.1M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -2959.9%，领先2811.6%），Cibus, Inc.同比增速更快（-12.8% vs -25.8%），过去两年Cibus, Inc.的营收复合增速更高（39.3% vs -4.5%）
Cibus Inc.是一家领先的农业生物技术企业，专注于利用精准基因编辑技术开发可持续的优质作物性状，涵盖抗除草剂、抗病抗虫、产量提升等解决方案，服务全球农业市场、种子生产商及种植群体，助力降低农业生产环境负担，提高生产效率。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
CBUS vs RKDA — 直观对比
营收规模更大
CBUS
是对方的1.2倍
$901.0K
营收增速更快
CBUS
高出13.1%
-25.8%
净利率更高
RKDA
高出2811.6%
-2959.9%
两年增速更快
CBUS
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $901.0K |
| 净利润 | $-31.3M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -2135.7% | -152.8% |
| 净利率 | -2959.9% | -148.3% |
| 营收同比 | -12.8% | -25.8% |
| 净利润同比 | -35.4% | 67.1% |
| 每股收益（稀释后） | $-0.39 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBUSRKDA
| Q4 25 | $1.1M | $901.0K | ||
| Q3 25 | $615.0K | $1.3M | ||
| Q2 25 | $933.0K | $1.5M | ||
| Q1 25 | $1.0M | $1.2M | ||
| Q4 24 | $1.2M | $1.2M | ||
| Q3 24 | $1.7M | $1.5M | ||
| Q2 24 | $838.0K | $1.3M | ||
| Q1 24 | $545.0K | $987.0K |
净利润CBUSRKDA
| Q4 25 | $-31.3M | $-1.3M | ||
| Q3 25 | $-23.5M | $856.0K | ||
| Q2 25 | $-25.4M | $-4.5M | ||
| Q1 25 | $-46.9M | $2.6M | ||
| Q4 24 | $-23.1M | $-4.1M | ||
| Q3 24 | $-180.0M | $-1.6M | ||
| Q2 24 | $-24.9M | $1.1M | ||
| Q1 24 | $-23.4M | $-2.4M |
毛利率CBUSRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率CBUSRKDA
| Q4 25 | -2135.7% | -152.8% | ||
| Q3 25 | -2510.2% | -88.5% | ||
| Q2 25 | -1923.5% | -34.4% | ||
| Q1 25 | -4020.4% | 44.2% | ||
| Q4 24 | -1487.1% | -187.7% | ||
| Q3 24 | -12023.8% | -114.5% | ||
| Q2 24 | -2563.5% | — | ||
| Q1 24 | -3385.9% | -160.9% |
净利率CBUSRKDA
| Q4 25 | -2959.9% | -148.3% | ||
| Q3 25 | -3827.8% | 65.7% | ||
| Q2 25 | -2719.4% | -306.4% | ||
| Q1 25 | -4534.4% | 216.6% | ||
| Q4 24 | -1906.1% | -334.5% | ||
| Q3 24 | -10795.9% | -104.9% | ||
| Q2 24 | -2969.3% | 81.2% | ||
| Q1 24 | -4300.0% | -245.5% |
每股收益（稀释后）CBUSRKDA
| Q4 25 | $-0.39 | $-0.97 | ||
| Q3 25 | $-0.44 | $0.62 | ||
| Q2 25 | $-0.61 | $-3.26 | ||
| Q1 25 | $-1.34 | $1.90 | ||
| Q4 24 | $-0.94 | $-2.99 | ||
| Q3 24 | $-7.63 | $-1.18 | ||
| Q2 24 | $-1.14 | $0.78 | ||
| Q1 24 | $-1.12 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $4.6M |
| 总债务越低越好 | $528.0K | — |
| 股东权益账面价值 | $21.8M | $4.1M |
| 总资产 | $305.0M | $6.5M |
| 负债/权益比越低杠杆越低 | 0.02× | — |
8季度趋势，按日历期对齐
现金及短期投资CBUSRKDA
| Q4 25 | $9.9M | $4.6M | ||
| Q3 25 | $23.9M | $5.9M | ||
| Q2 25 | $36.5M | $4.4M | ||
| Q1 25 | $23.6M | $3.2M | ||
| Q4 24 | $14.4M | $4.2M | ||
| Q3 24 | $28.8M | $6.6M | ||
| Q2 24 | $30.0M | $8.1M | ||
| Q1 24 | $24.5M | $8.5M |
总债务CBUSRKDA
| Q4 25 | $528.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $662.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CBUSRKDA
| Q4 25 | $21.8M | $4.1M | ||
| Q3 25 | $50.4M | $5.4M | ||
| Q2 25 | $72.1M | $4.5M | ||
| Q1 25 | $70.3M | $8.9M | ||
| Q4 24 | $92.2M | $6.2M | ||
| Q3 24 | $108.1M | $10.3M | ||
| Q2 24 | $270.5M | $11.7M | ||
| Q1 24 | $278.2M | $10.6M |
总资产CBUSRKDA
| Q4 25 | $305.0M | $6.5M | ||
| Q3 25 | $330.2M | $8.6M | ||
| Q2 25 | $346.2M | $7.8M | ||
| Q1 25 | $335.0M | $13.0M | ||
| Q4 24 | $350.1M | $13.5M | ||
| Q3 24 | $367.9M | $15.2M | ||
| Q2 24 | $553.4M | $17.4M | ||
| Q1 24 | $533.0M | $16.0M |
负债/权益比CBUSRKDA
| Q4 25 | 0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.4M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-13.5M | — |
| 自由现金流率自由现金流/营收 | -1277.8% | — |
| 资本支出强度资本支出/营收 | 8.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-51.2M | — |
8季度趋势，按日历期对齐
经营现金流CBUSRKDA
| Q4 25 | $-13.4M | $-861.0K | ||
| Q3 25 | $-11.7M | $-257.0K | ||
| Q2 25 | $-13.6M | $-2.0M | ||
| Q1 25 | $-11.8M | $-1.6M | ||
| Q4 24 | $-14.0M | $-2.2M | ||
| Q3 24 | $-13.5M | $-1.8M | ||
| Q2 24 | $-17.0M | $-2.5M | ||
| Q1 24 | $-13.5M | $-3.2M |
自由现金流CBUSRKDA
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-11.8M | — | ||
| Q2 25 | $-13.7M | — | ||
| Q1 25 | $-12.1M | — | ||
| Q4 24 | $-14.1M | — | ||
| Q3 24 | $-13.9M | — | ||
| Q2 24 | $-17.2M | $-2.5M | ||
| Q1 24 | $-13.7M | $-3.2M |
自由现金流率CBUSRKDA
| Q4 25 | -1277.8% | — | ||
| Q3 25 | -1926.5% | — | ||
| Q2 25 | -1468.1% | — | ||
| Q1 25 | -1172.0% | — | ||
| Q4 24 | -1159.3% | — | ||
| Q3 24 | -832.3% | — | ||
| Q2 24 | -2054.5% | -188.3% | ||
| Q1 24 | -2515.2% | -326.5% |
资本支出强度CBUSRKDA
| Q4 25 | 8.1% | 0.0% | ||
| Q3 25 | 17.6% | 0.0% | ||
| Q2 25 | 10.0% | 0.0% | ||
| Q1 25 | 28.1% | 0.0% | ||
| Q4 24 | 4.6% | 0.0% | ||
| Q3 24 | 21.3% | 0.0% | ||
| Q2 24 | 20.2% | 0.2% | ||
| Q1 24 | 41.8% | 1.3% |
现金转化率CBUSRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
